Patents/Assignees

SERODUS APS

2 patents in portfolio

US12440535utility2025
IL-4 Derived Peptide Fragments for Use in the Treatment of Diabetic Nephropathy
0 cites
US12378294utility2025
IL-4 Derived Peptides for Use in the Treatment of Obesity
0 cites